Bard Associates’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,185
| Closed | -$143K | – | 183 |
|
|
2025
Q1 | $143K | Sell |
25,185
-1,585
| -6% | -$20.3K | 0.05% | 158 |
|
|
2024
Q4 | $565K | Sell |
26,770
-4,470
| -14% | -$103K | 0.19% | 117 |
|
|
2024
Q3 | $840K | Buy |
31,240
+1,540
| +5% | +$45.4K | 0.29% | 103 |
|
|
2024
Q2 | $846K | Buy |
29,700
+568
| +2% | +$19.9K | 0.32% | 94 |
|
|
2024
Q1 | $1.24M | Buy |
29,132
+590
| +2% | +$26.5K | 0.44% | 80 |
|
|
2023
Q4 | $1.53M | Sell |
28,542
-50
| -0.2% | -$2.26K | 0.58% | 64 |
|
|
2023
Q3 | $1.23M | Sell |
28,592
-100
| -0.3% | -$4.61K | 0.51% | 71 |
|
|
2023
Q2 | $1.58M | Sell |
28,692
-438
| -2% | -$24K | 0.61% | 58 |
|
|
2023
Q1 | $1.22M | Sell |
29,130
-200
| -0.7% | -$5.93K | 0.51% | 64 |
|
|
2022
Q4 | $812K | Sell |
29,330
-500
| -2% | -$12.3K | 0.35% | 95 |
|
|
2022
Q3 | $764K | Sell |
29,830
-40
| -0.1% | -$1.32K | 0.34% | 92 |
|
|
2022
Q2 | $1.07M | Buy |
29,870
+850
| +3% | +$38.4K | 0.46% | 78 |
|
|
2022
Q1 | $1.8M | Hold |
29,020
| – | – | 0.64% | 59 |
|
|
2021
Q4 | $2.05M | Sell |
29,020
-450
| -2% | -$32K | 0.67% | 52 |
|
|
2021
Q3 | $2.06M | Hold |
29,470
| – | – | 0.69% | 56 |
|
|
2021
Q2 | $2.46M | Sell |
29,470
-37
| -0.1% | -$2.62K | 0.8% | 48 |
|
|
2021
Q1 | $1.61M | Sell |
29,507
-150
| -0.5% | -$7.3K | 0.58% | 67 |
|
|
2020
Q4 | $1.27M | Sell |
29,657
-15
| -0.1% | -$560 | 0.5% | 73 |
|
|
2020
Q3 | $893K | Sell |
29,672
-355
| -1% | -$11.9K | 0.47% | 76 |
|
|
2020
Q2 | $931K | Sell |
30,027
-1,250
| -4% | -$33.7K | 0.52% | 74 |
|
|
2020
Q1 | $691K | Buy |
31,277
+165
| +0.5% | +$4.47K | 0.51% | 77 |
|
|
2019
Q4 | $949K | Sell |
31,112
-80
| -0.3% | -$2.3K | 0.48% | 75 |
|
|
2019
Q3 | $959K | Sell |
31,192
-658
| -2% | -$16.4K | 0.49% | 77 |
|
|
2019
Q2 | $637K | Sell |
31,850
-17
| -0.1% | -$498 | 0.32% | 96 |
|
|
2019
Q1 | $1.37M | Sell |
31,867
-330
| -1% | -$12K | 0.69% | 57 |
|
|
2018
Q4 | $1.02M | Sell |
32,197
-410
| -1% | -$16.2K | 0.59% | 68 |
|
|
2018
Q3 | $1.71M | Sell |
32,607
-300
| -0.9% | -$16.8K | 0.79% | 43 |
|
|
2018
Q2 | $1.76M | Sell |
32,907
-370
| -1% | -$19K | 0.82% | 41 |
|
|
2018
Q1 | $1.66M | Sell |
33,277
-1,460
| -4% | -$65.5K | 0.83% | 38 |
|
|
2017
Q4 | $1.15M | Sell |
34,737
-150
| -0.4% | -$5.06K | 0.55% | 79 |
|
|
2017
Q3 | $1.31M | Sell |
34,887
-295
| -0.8% | -$8.73K | 0.61% | 64 |
|
|
2017
Q2 | $897K | Hold |
35,182
| – | – | 0.41% | 92 |
|
|
2017
Q1 | $915K | Sell |
35,182
-771
| -2% | -$22.2K | 0.43% | 86 |
|
|
2016
Q4 | $1.1M | Sell |
35,953
-460
| -1% | -$11.7K | 0.51% | 76 |
|
|
2016
Q3 | $990K | Sell |
36,413
-120
| -0.3% | -$3.33K | 0.48% | 77 |
|
|
2016
Q2 | $1.04M | Sell |
36,533
-1,260
| -3% | -$40.1K | 0.55% | 68 |
|
|
2016
Q1 | $1.14M | Buy |
37,793
+2,045
| +6% | +$58K | 0.66% | 62 |
|
|
2015
Q4 | $1.24M | Sell |
35,748
-2,075
| -5% | -$71K | 0.73% | 50 |
|
|
2015
Q3 | $1.43M | Sell |
37,823
-620
| -2% | -$28.8K | 0.82% | 46 |
|
|
2015
Q2 | $2.19M | Sell |
38,443
-1,030
| -3% | -$58.6K | 1.09% | 25 |
|
|
2015
Q1 | $2.3M | Sell |
39,473
-660
| -2% | -$35.5K | 1.1% | 23 |
|
|
2014
Q4 | $2.28M | Sell |
40,133
-100
| -0.2% | -$4.76K | 1.06% | 26 |
|
|
2014
Q3 | $1.65M | Sell |
40,233
-40
| -0.1% | -$1.84K | 0.77% | 52 |
|
|
2014
Q2 | $1.83M | Sell |
40,273
-300
| -0.7% | -$12.6K | 0.72% | 48 |
|
|
2014
Q1 | $1.92M | Sell |
40,573
-200
| -0.5% | -$9.1K | 0.81% | 39 |
|
|
2013
Q4 | $1.91M | Sell |
40,773
-13,468
| -25% | -$588K | 0.8% | 40 |
|
|
2013
Q3 | $2.16M | Sell |
54,241
-19
| -0% | -$747 | 0.96% | 29 |
|
|
2013
Q2 | $1.93M | Buy |
+54,260
| New | +$2.08M | 0.9% | 35 |
|
Other funds holding HBIO
AE
HP
GIM
MIM
